Evidence map›Paper›PMID 28670383›Full record

ArticleAmerican journal of translational research2017

MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells

Da-Peng Li, Juan Fan, Yong-Jun Wu, Yu-Feng Xie, Juan-Min Zha, Xiu-Min Zhou

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Dairy consumption and hepatocellular carcinoma risk.Annals of translational medicine · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Da-Peng LiDepartment of Oncology, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, People's Republic of China.
Juan FanDepartment of Oncology, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, People's Republic of China.
Yong-Jun WuDepartment of Urology, The 477 Hospital of PLAXiangyang, Hubei Province, People's Republic of China.
Yu-Feng XieDepartment of Oncology, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, People's Republic of China.
Juan-Min ZhaDepartment of Oncology, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, People's Republic of China.
Xiu-Min ZhouDepartment of Oncology, The First Affiliated Hospital of Soochow UniversitySuzhou 215006, Jiangsu Province, People's Republic of China.
Soochow University · CNDeyang Stomatological Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has previously been reported that microRNA (miR)-155 is linked to the recurrence and prognosis of hepatocellular carcinoma (HCC) following liver transplantation. However, the role of miR-155 in the invasion and metastasis of HCC cells remains largely unclear. The aim of this study was to investigate the expression of miR-155 in HCC cells and its role in the invasion and migration of HCC cells

Indexed as

EMThepatocellular carcinomainvasionmigrationmiR-155TGF-β1

Identifiers

PMID28670383
PMCPMC5489895
OpenAlexW3023662224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.